Menu Fermer

Ezetimibe : A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia

Montenegro-Miranda PS, Sneitz N, de Waart DR, Ten Bloemendaal L, Duijst S, de Knegt RJ, Beuers U, Finel M, Bosma PJ.

Tytgat Institute for Intestinal and Liver Research, Academic Medical Center of the University of Amsterdam, Meibergdreef 1105BK, Amsterdam, The Netherlands.